Guidance

Supply and management of homecare medicines review and implementation

An alert to the review and implementation of homecare medicines and the associated implementation arrangements has been sent to the NHS.

Document

National Homecare Medicines Review and Implementation

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This letter from Mark Hackett, Chief Executive of University Hospital Southampton, has been sent to NHS commissioners and providers. It highlights potential benefits delivered by acute trusts and commissioners working in partnership.

The benefits for organisations can include:

  • improved internal governance arrangements
  • protection of the statutory responsibilities of chief pharmacists for the supply and dispensing of homecare medicines in a treatment setting
  • improved working with commissioners and individuals
  • improved cost efficiency and savings from VAT and other supplier delivered benefits.

There is potential to further develop homecare medicines services.  Read the report achieving savings from high cost drugs

Published 29 November 2012